about
Carvedilol in the treatment of hypertension--a review of the clinical data base.Pharmacological conversion of recent-onset atrial fibrillation: a systematic review.Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.Hypertension-induced congestive heart failure.Early and late sympathetic activation in hypertension.Vascular remodeling and endothelial function in hypertensive patients: effects of antihypertensive therapy.Clinical consequences of the autonomic imbalance in hypertension and congestive heart failure.Treating hypertension--effect of treatment and cost-effectiveness in respect to later cardiovascular diseases.Molecular genetics of congestive heart failure.Beta-adrenergic blockade in chronic heart failure.Betablockers: old concept in a modern approach.New hormonal blockade strategies in cardiovascular disease.Assessment of left ventricular dysfunction and remodeling by determination of atrioventricular plane displacement and simplified echocardiography.Serum cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease. Experiences from a hospital-based secondary prevention programme.Milrinone and levosimendan administered after reperfusion improve myocardial stunning in swine.Aortic regurgitation after transcatheter aortic valve implantation of the Edwards SAPIEN ™ valve.Release and effects of calcitonin gene-related peptide in myocardial ischaemia.Preoperative NT-proBNP independently predicts outcome in patients with acute coronary syndrome undergoing CABG.Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein.Sildenafil after cardiac arrest and infarction; an experimental rat model.XVIth Nordic congress of cardiology. Tampere, Finland, June 11-13, 1997. Abstracts17th Nordic Congress of Cardiology, Reykjavik, Iceland, June 9-11, 1999. AbstractsFrom Hypertension to Heart Failure. Symposium proceedings. Stockholm, Sweden, January 1997Abstracts from XIX Nordic Congress of Cardiology. Odense, Denmark, June 4-6, 2003Abstracts from the IX Swedish Cardiovascular Meeting, Goteborg, April 25-27, 2007Abstracts from VII Swedish Heart Association Meeting and the XX Nordic Congress of Cardiology. Malmo, Sweden, April 27-29, 2005Abstracts from the Xth Swedish Heart Association Meeting, April 23-25, 2008, Malmo, SwedenAbstracts from VIII Swedish Heart Association meeting, Linköping, Sweden, April 26-28, 2006Abstracts from the XI Swedish Heart Association, April 22-24, 2009, Uppsala, SwedenAbstracts from the XII Meeting of the Swedish Heart Association, April 21-23 2010, Gothenburg, SwedenSimilar survival 15 years after coronary artery surgery irrespective of left main stem stenosisAbstracts of the XV Swedish Cardiovascular Spring Meeting. Göteborg, Sweden. April 17–19, 2013Left ventricular systolic dyssynchrony in patients with isolated symptomatic myocardial bridge
P1433
Q32068461-6D500F21-4F5D-4EF9-B147-401E9EA66818Q38052164-402BC536-B28A-482D-81C8-56298DDD2694Q41572598-433BCFA9-0178-4112-9575-561811BF339CQ41737468-D9B243AA-56F0-4A7A-9ACF-1803E4A4D9BEQ41737472-5E7D06B0-EDC1-4351-B50D-0608B6DCAE6FQ41737479-E94123B9-A9F7-4B4E-AFD4-39C3FFABD8FDQ41737485-5DC102C0-E326-43D2-80D4-9E2F05BE7B45Q41737489-9497A744-6415-4A5E-9C91-C45086F1E3DEQ41737493-D85DE70C-DEB5-40C9-8DF0-E3DB5B74BE20Q41737497-3DFE9C21-471D-4BB8-9106-1DB7842CF629Q41737503-C644E627-3529-4291-928A-908FB0A09AEFQ41737508-F22C27FE-9C5E-41CF-A9DA-AE1CAD771E07Q44602812-A16B3C17-D455-4BB3-940E-1DCBCF37B649Q44816160-6D9DCB2E-E16B-48B9-A65C-38C8E643C012Q44890651-085D639D-55F4-4D79-8144-5E541F44AC5BQ46032781-B563D8BD-C489-4331-B65C-7121FEDB3B01Q46169296-7D7FA07E-8DB0-4885-B835-76D78E0D2105Q48130022-B2E2C6E1-02CB-4164-A0D3-D935F37870EEQ52886658-930BA278-2051-41BD-AF96-9C280AE6BA46Q54291313-E5E53C7D-04E9-4783-B4C0-7F99CB355EC2Q73611863-C742F04D-B65A-4D96-B826-6819D960E201Q74040576-A77D558A-412E-4328-BB78-AF3280FD57EBQ74583156-EEA78103-795A-469A-A18F-19FE39A2710AQ75184792-FE60853C-5BB9-41B5-8CD1-608BBC769B73Q80707346-D4115731-90AD-46A3-8B6A-7C50467F653BQ81604349-BA6AE807-1F55-4245-8EC9-34F689494BEFQ81699470-CBF4A017-FDFD-45EE-9030-4A3BBD197FF8Q83205781-B021E399-2E11-4694-9875-0EE263EB7682Q83508899-E1B3E497-59D2-42D7-B4F4-FA152C18A9DCQ84053396-95B5A45A-67A0-454A-9F6B-640CD39D7523Q85003909-1833CE2E-BE89-4570-BA8B-CC4E22D323B9Q86456362-F2E21C63-40B4-4958-AAAE-15A27C36CD68Q87409868-8FA27053-F009-404A-BF3A-C054743A28D1
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Taylor & Francis
@nl
wissenschaftliche Fachzeitschrift
@de
name
Scandinavian cardiovascular journal. Supplement
@ast
Scandinavian cardiovascular journal. Supplement
@en
Scandinavian cardiovascular journal. Supplement
@es
Scandinavian cardiovascular journal. Supplement
@it
Scandinavian cardiovascular journal. Supplement
@nl
type
label
Scandinavian cardiovascular journal. Supplement
@ast
Scandinavian cardiovascular journal. Supplement
@en
Scandinavian cardiovascular journal. Supplement
@es
Scandinavian cardiovascular journal. Supplement
@it
Scandinavian cardiovascular journal. Supplement
@nl
altLabel
Scand Cardiovasc J Suppl
@en
prefLabel
Scandinavian cardiovascular journal. Supplement
@ast
Scandinavian cardiovascular journal. Supplement
@en
Scandinavian cardiovascular journal. Supplement
@es
Scandinavian cardiovascular journal. Supplement
@it
Scandinavian cardiovascular journal. Supplement
@nl
P1055
P1156
P123
P1277
P1476
Scandinavian cardiovascular journal. Supplement
@en